ICY:FRA
Incyte Corp
€100.05
arrow_downward
-1.09%(-1.10) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
€100.05
High
€100.05
Low
€100.05
Mkt. cap
22.86B
Avg. vol.
30.00
Volume
0.00
52-wk high
€115.40
52-wk low
€72.28
No. of employees
3K
Open
€100.05
High
€100.05
Low
€100.05
Mkt. cap
22.86B
Avg. vol.
30.00
Volume
0.00
52-wk high
€115.40
52-wk low
€72.28
No. of employees
3K
News stories
From web sources and news partners
TipRanks
·
5 hours ago
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
Barchart.com
·
11 hours ago
What to Expect From Incyte’s Next Quarterly Earnings Report
Simply Wall Street
·
19 hours ago
Is Rare Disease Approval Altering The Investment Case For Incyte (INCY)?
BioSpace
·
1 day ago
Incyte to Report Third Quarter 2026 Financial Results
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com